{
    "2019-12-08": [
        [
            {
                "time": "",
                "original_text": "【国盛医药张金洋团队】周观点：智飞生物研发管线有望获得市场重估，“销售+研发”双轮驱动",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "研发管线",
                        "市场重估",
                        "销售",
                        "研发",
                        "双轮驱动"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}